| Q27649855 | Bifunctional NMN Adenylyltransferase/ADP-Ribose Pyrophosphatase: Structure and Function in Bacterial NAD Metabolism |
| Q34500497 | Biogenesis and Homeostasis of Nicotinamide Adenine Dinucleotide Cofactor |
| Q35747152 | CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy |
| Q34563272 | Comparative genomics of NAD biosynthesis in cyanobacteria. |
| Q27662749 | Complexes of Bacterial Nicotinate Mononucleotide Adenylyltransferase with Inhibitors: Implication for Structure-Based Drug Design and Improvement |
| Q38121170 | Diversification of NAD biological role: the importance of location |
| Q38450536 | Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target |
| Q41454387 | Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship |
| Q33897963 | Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases |
| Q37283423 | Less is more: Nutrient limitation induces cross-talk of nutrient sensing pathways with NAD(+) homeostasis and contributes to longevity |
| Q38613938 | Metabolic Signaling to Chromatin |
| Q34572320 | Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues |
| Q38101602 | NAD and ADP-ribose metabolism in mitochondria |
| Q34518882 | NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration |
| Q37984791 | NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. |
| Q36596234 | NAD+ utilization in Pasteurellaceae: simplification of a complex pathway. |
| Q37379693 | NMNATs, evolutionarily conserved neuronal maintenance factors. |
| Q34003813 | Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery |
| Q27653693 | Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis |
| Q34607796 | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme |
| Q24669960 | Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? |
| Q34629538 | Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration |
| Q34622726 | Regulation of NAD+ metabolism, signaling and compartmentalization in the yeast Saccharomyces cerevisiae |
| Q34541823 | Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues |
| Q38012434 | Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model |
| Q42516136 | The role of autophagy in Nmnat-mediated protection against hypoxia-induced dendrite degeneration. |
| Q30476859 | The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus |
| Q34106847 | Wallerian degeneration, wld(s), and nmnat |
| Q27935107 | YCL047C/POF1 is a novel nicotinamide mononucleotide adenylyltransferase (NMNAT) in Saccharomyces cerevisiae |